课题基金 / 基金详情

Relations between development of insulitis and expression of adhesion molecules in multiple low-dose streptozotocin-treated mice.

Relations between development of insulitis and expression of adhesion molecules in multiple low-dose streptozotocin-treated mice.
多只低剂量链脲佐菌素治疗的小鼠中胰岛素炎的发生与粘附分子表达之间的关系。
批准号:
06660381
负责人:
HAYASHI Toshiharu
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

HAYASHI Toshiharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary consisted of five papers listed bellow.Multiple low-dose streptozotocin (SZ) -induced insulitis is an animal model for human insulin-dependent diabetes mellitus (IDDM) characterized by a mononuclear cell infiltration. SZ-induced insulitis and blood glucose concentrations were reduced by treatment with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies (Ref.1). ICAM-1 expression on vascular endothelial cells increased in parallel to the degree of insulitis. Also NZBxNZWF1 mice, which is an animal model for human systemic lupus erythematosus, showed increased accumulation of neutrophils, macrophages, T and CD4 <plus-minus> cells expressing LFA-1 molecule within glomeruli during the development of glomerulonephritis (GN). The NZBxNZWF1 mice exhibited an age-related and profound increase in ICAM-1 expression associated with the development of GN (Ref.3). In LDV infected mice, suppressed expression of these molecules was related with the suppression of insulitis or GN (Ref.1-3). This suppressive effect in LDV-infected mice may not be due to altered IL-6 production by macrophages (Ref.4). On the other hand, reovirus type 2-induced diabetes-like syndrome in suckling DBA/1 mice is considered to be another animal model for human IDDM.The treatment with monoclonal antibodies against ICAM-1 and LFA-1 prevented the development of insulitis with abnormal glucose tolerance (Ref.5). In conclusion, our observations indicate a potential therapeutic application of these antibodies in certain autoimmune disease
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
T.Hayashi: "Effect of infection by LDV on expression of ICAM-1 on vascular endothelial cells of pancreatic islets in SZ-incluced insulitis of CD-1 mice" Int.J.Exp.Path.75. 211-217 (1994)
T.Hayashi:“LDV 感染对 CD-1 小鼠 SZ 性胰岛炎中胰岛血管内皮细胞 ICAM-1 表达的影响”Int.J.Exp.Path.75。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwata, H.and Hayashi, T.: "Interleukin-6 production by macrophages from BALB/c mice with a chronic infection of lactic dehydrogenase virus." Exp.Anim.43. 559-562 (1994)
Iwata, H. 和 Hayashi, T.:“慢性感染乳酸脱氢酶病毒的 BALB/c 小鼠巨噬细胞产生白介素 6。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Destruction of niche and target-cells in autoimmune diseases by effector cells and molecules
    • 批准号:
      21580362
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    Mechanisms and treatments of autoimmune diseases by Th1/Th2 unbalance
    • 批准号:
      15380210
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.32万
    • 财政年份:
      2003
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    Gene therapy for autoimmune diabetes by DNA vaccine
    • 批准号:
      13660318
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2001
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    Studies on pathogenesis, prevention and treatment of serious diseases.
    • 批准号:
      10660302
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1998
    • 负责人:
      HAYASHI Toshiharu
    • 依托单位:
    国内基金
    海外基金
    GRP78保护胰岛β细胞与重建IDDM免疫耐受效应与机制研究
    • 批准号:
      30972734
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2009
    • 负责人:
      沈关心
    • 依托单位:
    预防和治疗胰岛素依赖型糖尿病(IDDM)的新方法- - 利用ILA微小肽段诱导针对自身胰岛抗原免疫耐受的研究
    • 批准号:
      30671003
    • 项目类别:
      面上项目
    • 资助金额:
      27.0万元
    • 批准年份:
      2006
    • 负责人:
      魏承宏
    • 依托单位:
    IDDM发病中感染性耐受的建立和机制研究
    • 批准号:
      30200343
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2002
    • 负责人:
      向明
    • 依托单位:
    人工合成脂类抗原α-Galcer治疗IDDM的动物实验研究
    • 批准号:
      30070709
    • 项目类别:
      面上项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2000
    • 负责人:
      王福庆
    • 依托单位: